To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ISG20TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
160 supporting clones for gene ISG20 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI838264 pooled pancreas and spleen ISG20.a 1 to 803 1 to 799 R172E G173A L174A P175R R176L ... tiling clone,   799/850
(94 %)
7 diff
(99.2 %id)
TI_57162902   ISG20.a 1 to 803 64 to 862 R172E G173A L174A P175R R176L ...     799/913
(87 %)
15 diff
(98.4 %id)
BM691295 eye, RPE and Choroid ISG20.b 1 to 439 1 to 440   tiling clone, fully sequenced,   440/440
(100 %)
6 diff
(98.7 %id)
BG685777 B-cells, primary B-cells from tonsils (cell line) ISG20.b 26 to 759 1 to 734 L177W A178L V179C S180Q D181T tiling clone, AAA   734/734
(100 %)
5 diff
(99.4 %id)
TI_57146061   ISG20.b 47 to 750 61 to 765 exact tiling clone,   705/1088
(64 %)
9 diff
(99.2 %id)
BI759236 pooled colon, kidney, stomach ISG20.b 52 to 750 1 to 700 exact     700/1023
(68 %)
3 diff
(99.8 %id)
CV023075 mixed ISG20.b 96 to 477 1 to 382       382/382
(100 %)
11 diff
(97.2 %id)
CV030119 mixed ISG20.b 96 to 166 1 to 71       71/74
(95 %)
5 diff
(93.3 %id)
CN265231 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ISG20.b 100 to 518 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
AW001293 colon, colonic mucosa from 3 patients with Crohn'sdisease ISG20.b 152 to 466 320 to 6       315/331
(95 %)
11 diff
(96.7 %id)
BE350909 malignant melanoma, metastatic to lymphnode, skin ISG20.b 321 to 751 434 to 4       431/434
(99 %)
1 diff
(99.8 %id)
AA962779 2 pooled tumors (clear cell type), Kidney ISG20.b 322 to 735 411 to 1       411/424
(96 %)
9 diff
(97.9 %id)
AI864436 anaplastic oligodendroglioma, brain ISG20.b 322 to 730 410 to 2       409/529
(77 %)
6 diff
(98.9 %id)
AA628001 colon, colon tumor RER+ ISG20.b 324 to 753 429 to 1   tiling clone,   429/429
(100 %)
2 diff
(99.6 %id)
BG183391   ISG20.b 326 to 656 54 to 382       329/382
(86 %)
13 diff
(96.6 %id)
AW297796   ISG20.b 347 to 529 18 to 200     Submitted on the opposite strand 183/205
(89 %)
13 diff
(93.7 %id)
BU726478 eye, RPE and Choroid ISG20.b 409 to 732 342 to 19   fully sequenced, AAA   324/324
(100 %)
1 diff
(99.7 %id)
BG756862 B-cells, primary B-cells from tonsils (cell line) ISG20.c 1 to 746 1 to 747   tiling clone,   747/747
(100 %)
2 diff
(99.8 %id)
BG759382 B-cells, primary B-cells from tonsils (cell line) ISG20.c 1 to 590 1 to 590       590/590
(100 %)
1 diff
(99.9 %id)
CD672839 eye, Iris ISG20.c 45 to 703 1 to 659       659/659
(100 %)
0 diff
(100 %id)
CR619922 Placenta Cot 25-normalized ISG20.c 63 to 1823 1 to 1761 exact tiling clone,   1761/1761
(100 %)
0 diff
(100 %id)
BX339191 Placenta Cot 25-normalized ISG20.c 63 to 994 1 to 927 G83A K84S L85W V86W V87W ... fully sequenced,   927/927
(100 %)
5 diff
(99.5 %id)
BF663747 B-cells, primary B-cells from tonsils (cell line) ISG20.c 66 to 793 1 to 727       727/976
(74 %)
24 diff
(97.6 %id)
BG759531 B-cells, primary B-cells from tonsils (cell line) ISG20.c 66 to 755 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
BC007922 Primary B-Cells from Tonsils ISG20.c 67 to 1022 1 to 956 exact available from MGC, AAA   956/956
(100 %)
2 diff
(99.8 %id)
NM_002201.4   ISG20.c 67 to 1022 1 to 956 exact RefSeq, AAA   956/956
(100 %)
2 diff
(99.8 %id)
BM754903 stomach ISG20.c 190 to 543 1 to 354       354/354
(100 %)
0 diff
(100 %id)
CB114442 Liver ISG20.c 194 to 404 1 to 211       211/211
(100 %)
0 diff
(100 %id)
CB114498 Liver ISG20.c 194 to 404 1 to 211       211/211
(100 %)
0 diff
(100 %id)
CB125224 Liver ISG20.c 194 to 689 1 to 496       496/496
(100 %)
0 diff
(100 %id)
CB125068 Liver ISG20.c 194 to 779 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
CB126461 Liver ISG20.c 194 to 573 1 to 380       380/380
(100 %)
0 diff
(100 %id)
CB126685 Liver ISG20.c 194 to 605 1 to 412       412/412
(100 %)
0 diff
(100 %id)
CB125863 Liver ISG20.c 194 to 404 1 to 211       211/211
(100 %)
0 diff
(100 %id)
CB125783 Liver ISG20.c 194 to 437 1 to 244       244/244
(100 %)
0 diff
(100 %id)
AK307769 alzheimer cortex ISG20.c 199 to 1718 1 to 1515 P45G E46R G47D E48H I49R ...     1515/1515
(100 %)
7 diff
(99.6 %id)
TI_149311462   ISG20.c 199 to 996 885 to 90 G3E S4N A9P H20P R21P ... AAA   796/939
(84 %)
27 diff
(97.2 %id)
DA133587 alzheimer cortex ISG20.c 200 to 757 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
BU860218 adenocarcinoma, cell line, breast ISG20.c 207 to 998 1 to 801 W117G S151A L174A P175A R176P ...     801/944
(84 %)
22 diff
(97.7 %id)
CB120916 Liver ISG20.c 216 to 408 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BC094819 Skin, melanoma, melanotic ISG20.c 219 to 1023 488 to 1292 exact AAA   805/1292
(62 %)
6 diff
(99.6 %id)
BU594325 mixed (pool of 40 RNAs) ISG20.c 239 to 794 1 to 561       561/874
(64 %)
21 diff
(97.6 %id)
BP342030 stomach mucosa ISG20.c 243 to 827 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
CB126371 Liver ISG20.c 251 to 504 1 to 249       249/249
(100 %)
6 diff
(97.6 %id)
AA534009 invasive prostate tumor, Prostate ISG20.c 252 to 746 1 to 493       493/495
(99 %)
13 diff
(97.4 %id)
BF692496 melanotic melanoma, high MDR, skin ISG20.c 274 to 869 1 to 601       601/862
(69 %)
16 diff
(98.2 %id)
BM929924 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ISG20.c 275 to 618 1 to 344   fully sequenced,   344/344
(100 %)
1 diff
(99.8 %id)
BM930109 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ISG20.c 275 to 618 1 to 347   fully sequenced,   347/347
(100 %)
4 diff
(98.9 %id)
BU597010 mixed (pool of 40 RNAs) ISG20.c 283 to 587 1 to 308       308/944
(32 %)
8 diff
(99.2 %id)
BM915462 amelanotic melanoma, cell line, skin ISG20.c 284 to 1023 1 to 740 exact     740/1074
(68 %)
3 diff
(99.8 %id)
AA316487 colon ISG20.c 289 to 684 1 to 395       395/395
(100 %)
2 diff
(99.5 %id)
BG684192 B-cells, primary B-cells from tonsils (cell line) ISG20.c 289 to 1024 1 to 737 E76D I77D L78P Q79A L80A ...     737/902
(81 %)
7 diff
(99.3 %id)
BG684672 B-cells, primary B-cells from tonsils (cell line) ISG20.c 289 to 967 1 to 679 exact     679/679
(100 %)
0 diff
(100 %id)
BG684223 B-cells, primary B-cells from tonsils (cell line) ISG20.c 289 to 1024 1 to 736 exact     736/736
(100 %)
1 diff
(99.9 %id)
BG685917 B-cells, primary B-cells from tonsils (cell line) ISG20.c 289 to 977 1 to 697 R21G E22R S23V G24A L25W ...     697/857
(81 %)
22 diff
(97.5 %id)
TI_57167420   ISG20.c 291 to 1019 33 to 762 T68I     730/1149
(63 %)
11 diff
(99.1 %id)
TI_57167627   ISG20.c 291 to 1023 32 to 764 L177P A178G V179C S180V D181R AAA   733/764
(95 %)
11 diff
(98.6 %id)
BG035702 adenocarcinoma, cell line, Liver ISG20.c 292 to 1021 1 to 732 exact     732/752
(97 %)
7 diff
(99.1 %id)
BI835038 pooled pancreas and spleen ISG20.c 295 to 1019 1 to 726 T68I     726/1113
(65 %)
5 diff
(99.6 %id)
BI836675 pooled pancreas and spleen ISG20.c 295 to 1023 1 to 729 L177P A178G V179C S180V D181R AAA   729/729
(100 %)
6 diff
(99.2 %id)
AA345110 gall bladder ISG20.c 296 to 447 1 to 153       153/153
(100 %)
5 diff
(96.8 %id)
BG489248 large cell carcinoma, lung ISG20.c 296 to 872 1 to 585       585/589
(99 %)
11 diff
(98.2 %id)
BQ109535 pooled pancreas and spleen ISG20.c 300 to 678 1 to 379       379/379
(100 %)
14 diff
(96.4 %id)
BG542192 lung ISG20.c 304 to 901 1 to 625       623/939
(66 %)
47 diff
(95.0 %id)
BG340880 B-cells, primary B-cells from tonsils (cell line) ISG20.c 307 to 999 1 to 689 R176A L177G A178C S180R D181L     689/704
(97 %)
8 diff
(98.9 %id)
BQ708629 Spleen ISG20.c 310 to 901 1 to 595       595/976
(60 %)
22 diff
(97.8 %id)
CN265232 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ISG20.c 311 to 902 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
AA156704 uterus ISG20.c 314 to 618 1 to 312   fully sequenced,   312/312
(100 %)
7 diff
(97.8 %id)
BM043378 carcinoma, cell line, Prostate ISG20.c 314 to 1024 1 to 711 exact     711/785
(90 %)
3 diff
(99.7 %id)
AA300780 testis ISG20.c 322 to 597 1 to 276       276/292
(94 %)
11 diff
(96.3 %id)
BQ893097 melanotic melanoma, cell line, skin ISG20.c 323 to 749 1 to 426       426/934
(45 %)
10 diff
(99.0 %id)
U88964   ISG20.c 323 to 1023 1 to 701 exact AAA   701/701
(100 %)
1 diff
(99.9 %id)
BG490708 large cell carcinoma, lung ISG20.c 332 to 1023 1 to 693 exact     693/709
(97 %)
7 diff
(99.1 %id)
BF663296 B-cells, primary B-cells from tonsils (cell line) ISG20.c 333 to 1024 8 to 698 R74G L75*     691/932
(74 %)
19 diff
(98.0 %id)
BG774948 carcinoma, cell line, Prostate ISG20.c 333 to 1024 25 to 718 P45S E46* fully sequenced,   694/718
(96 %)
8 diff
(98.9 %id)
BG744069 blood, natural killer cells, cell line ISG20.c 339 to 1023 1 to 685 exact fully sequenced, AAA   685/685
(100 %)
0 diff
(100 %id)
BQ687397 ductal carcinoma, cell line, Pancreas ISG20.c 341 to 990 1 to 657 R167T R176P V179G     657/941
(69 %)
24 diff
(97.5 %id)
X89773   ISG20.c 345 to 1023 1 to 679 exact     679/679
(100 %)
1 diff
(99.9 %id)
BG766899 melanotic melanoma, high MDR (cell line), skin ISG20.c 348 to 943 1 to 617 P19G H20P R21T E22G S23R ...     615/846
(72 %)
27 diff
(96.9 %id)
BT006952   ISG20.c 360 to 903 1 to 544       544/546
(99 %)
2 diff
(99.7 %id)
CR456942   ISG20.c 360 to 901 1 to 542       542/546
(99 %)
2 diff
(99.7 %id)
AA903490 pooled germ cell tumors ISG20.c 406 to 1024 625 to 9       617/646
(95 %)
50 diff
(92.3 %id)
AI810940 Prostate ISG20.c 423 to 997 575 to 1       575/584
(98 %)
4 diff
(99.4 %id)
BE857745 Prostate ISG20.c 423 to 997 575 to 1       575/575
(100 %)
2 diff
(99.7 %id)
BF000519 colon, colon tumor, RER+ ISG20.c 423 to 1017 595 to 1       595/598
(99 %)
4 diff
(99.4 %id)
BM977367 lung, Primary Lung Cystic Fibrosis EpithelialCells ISG20.c 423 to 996 592 to 19   AAA   574/574
(100 %)
1 diff
(99.9 %id)
AI885714 anaplastic oligodendroglioma, brain ISG20.c 429 to 1023 624 to 30   AAA   595/595
(100 %)
39 diff
(93.5 %id)
BQ006403 Chondrosarcoma, Left Pelvis ISG20.c 430 to 1023 611 to 19   AAA   593/612
(96 %)
4 diff
(99.4 %id)
TI_149300545   ISG20.c 430 to 1023 687 to 95   AAA   593/615
(96 %)
2 diff
(99.7 %id)
TI_227715099   ISG20.c 435 to 1023 685 to 97   AAA   589/620
(95 %)
3 diff
(99.6 %id)
CD365595 Alveolar Macrophage, lung ISG20.c 435 to 1023 607 to 19   AAA   589/590
(99 %)
3 diff
(99.5 %id)
BM976594 lung, Primary Lung Cystic Fibrosis EpithelialCells ISG20.c 437 to 1023 605 to 19   AAA   587/587
(100 %)
1 diff
(99.9 %id)
CA307445 Alveolar Macrophage, lung ISG20.c 437 to 1023 605 to 19   AAA   587/587
(100 %)
1 diff
(99.9 %id)
BF057639 pooled germ cell tumors ISG20.c 459 to 900 442 to 1       442/442
(100 %)
18 diff
(96.0 %id)
CB068816 Pancreas, Purified pancreatic islet ISG20.c 462 to 1022 564 to 1       564/564
(100 %)
21 diff
(96.3 %id)
AA807337 germinal center B cell ISG20.c 501 to 996 505 to 12   AAA   494/494
(100 %)
5 diff
(99.0 %id)
AI479403 anaplastic oligodendroglioma, brain ISG20.c 513 to 996 484 to 1       484/484
(100 %)
5 diff
(99.0 %id)
AI363044 anaplastic oligodendroglioma, brain ISG20.c 531 to 996 468 to 1       468/468
(100 %)
3 diff
(99.4 %id)
AA931948 Kidney ISG20.c 537 to 996 459 to 1       459/462
(99 %)
8 diff
(98.3 %id)
AI085530 anaplastic oligodendroglioma, brain ISG20.c 554 to 1018 480 to 17   AAA   464/464
(100 %)
6 diff
(98.8 %id)
AA150500 uterus ISG20.c 557 to 1024 468 to 3   fully sequenced,   466/468
(99 %)
3 diff
(99.4 %id)
BG744737 blood, natural killer cells, cell line ISG20.c 557 to 975 419 to 2   fully sequenced,   418/419
(99 %)
0 diff
(100 %id)
BM684349 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ISG20.c 557 to 1023 485 to 19   fully sequenced, AAA   467/467
(100 %)
2 diff
(99.6 %id)
BM684740 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ISG20.c 557 to 1023 485 to 19   fully sequenced, AAA   467/467
(100 %)
1 diff
(99.8 %id)
BG057744 blood, lymphocyte ISG20.c 594 to 1026 432 to 1       432/432
(100 %)
53 diff
(87.8 %id)
AW768401 lymph node, lymphoma, follicular mixed small and largecell ISG20.c 633 to 1023 420 to 27   AAA   394/394
(100 %)
22 diff
(94.5 %id)
AW087688 pooled ISG20.c 649 to 999 353 to 1       353/353
(100 %)
3 diff
(99.2 %id)
AA477196 ovarian tumor, ovary ISG20.c 669 to 1006 1 to 337   fully sequenced,   337/337
(100 %)
2 diff
(99.5 %id)
BG775406 carcinoma, cell line, Prostate ISG20.c 673 to 949 277 to 1   fully sequenced,   277/277
(100 %)
1 diff
(99.7 %id)
AW295474   ISG20.c 700 to 1023 341 to 18   AAA   324/324
(100 %)
1 diff
(99.7 %id)
BE645034 pooled ISG20.c 702 to 1024 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
AI024765 breast ISG20.c 706 to 1018 313 to 1       313/313
(100 %)
2 diff
(99.4 %id)
BQ717792 dorsal root ganglia ISG20.c 710 to 1547 1 to 850       850/986
(86 %)
24 diff
(97.6 %id)
BF062088 pooled germ cell tumors ISG20.c 724 to 1019 303 to 8       296/303
(97 %)
1 diff
(99.7 %id)
AI928624 anaplastic oligodendroglioma, brain ISG20.c 732 to 1023 309 to 18   AAA   292/292
(100 %)
7 diff
(97.7 %id)
AA875935 2 pooled tumors (clear cell type), Kidney ISG20.c 798 to 999 204 to 3       202/204
(99 %)
0 diff
(100 %id)
AA888499 metastatic prostate bone lesion ISG20.c 804 to 1024 225 to 6       220/230
(95 %)
0 diff
(100 %id)
AI918256 anaplastic oligodendroglioma, brain ISG20.c 813 to 900 88 to 1       88/88
(100 %)
3 diff
(96.6 %id)
AA479795 ovarian tumor, ovary ISG20.c 818 to 1023 207 to 1   fully sequenced,   207/207
(100 %)
1 diff
(99.6 %id)
AI283917 esophagus, squamous cell carcinoma ISG20.c 846 to 1018 173 to 1       173/173
(100 %)
0 diff
(100 %id)
AA470680 colon ISG20.c 873 to 1022 166 to 17   AAA   150/150
(100 %)
0 diff
(100 %id)
BX339190 Placenta Cot 25-normalized ISG20.c 964 to 1823 853 to 1   fully sequenced,   853/853
(100 %)
1 diff
(99.9 %id)
BX114924 colon ISG20.c 1479 to 1856 1 to 377   AAA   377/377
(100 %)
2 diff
(99.5 %id)
AI334625 2 pooled tumors (clear cell type), Kidney ISG20.c 1499 to 1857 370 to 12   AAA   359/359
(100 %)
1 diff
(99.8 %id)
AI308170 2 pooled tumors (clear cell type), Kidney ISG20.c 1499 to 1857 368 to 10   tiling clone,   359/368
(97 %)
0 diff
(100 %id)
AA503824 colon ISG20.c 1517 to 1856 376 to 38   AAA   339/339
(100 %)
2 diff
(99.5 %id)
AK122793 thymus ISG20.d 1 to 2338 2 to 2339 exact tiling clone, available from FLJ,   2339/2339
(100 %)
9 diff
(99.7 %id)
DB118810 thymus ISG20.d 1 to 511 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
BX390929   ISG20.d 399 to 1324 1 to 927   tiling clone,   927/928
(99 %)
19 diff
(98.0 %id)
BX350662   ISG20.d 747 to 1627 858 to 1   tiling clone,   858/910
(94 %)
48 diff
(94.8 %id)
BX401662   ISG20.d 1298 to 2305 1003 to 1 F84X C114G L119C R120G V121C ... tiling clone,   1003/1065
(94 %)
22 diff
(98.0 %id)
BM782538 stomach ISG20.d 1660 to 2241 1 to 582 H34Y     582/582
(100 %)
3 diff
(99.5 %id)
AB209639 Spleen ISG20.e 1 to 5634 1 to 5634 exact tiling clone,   5634/5634
(100 %)
0 diff
(100 %id)
BX490702   ISG20.e 1322 to 1910 8 to 597       590/604
(97 %)
3 diff
(99.6 %id)
BF883885 lung_tumor ISG20.e 1455 to 1937 19 to 498       480/499
(96 %)
6 diff
(98.8 %id)
AJ711797 heart ISG20.e 1488 to 1757 271 to 1     Submitted on the opposite strand 271/281
(96 %)
2 diff
(99.3 %id)
BX490703   ISG20.e 5072 to 5607 555 to 20   AAA   536/536
(100 %)
0 diff
(100 %id)
AA505156 germinal center B cell ISG20.f 1 to 217 1 to 213   tiling clone, fully sequenced,   213/213
(100 %)
5 diff
(97.7 %id)
BF173818 blood ISG20.f 34 to 260 1 to 225   tiling clone,   225/226
(99 %)
12 diff
(94.7 %id)
AA872548 germinal center B cell ISG20.f 161 to 619 473 to 17   tiling clone, AAA   457/457
(100 %)
6 diff
(98.7 %id)
AA504805 germinal center B cell ISG20.f 201 to 592 406 to 15   tiling clone, fully sequenced, AAA   392/392
(100 %)
4 diff
(99.0 %id)
CN265233 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ISG20.g 1 to 614 1 to 614   tiling clone,   614/614
(100 %)
2 diff
(99.7 %id)
AI765047 Kidney ISG20.g 154 to 727 574 to 1       574/579
(99 %)
7 diff
(98.8 %id)
AI394335 B-cell, chronic lymphotic leukemia ISG20.g 210 to 746 537 to 1       537/541
(99 %)
4 diff
(99.3 %id)
AI738886 colon, colon tumor, RER+ ISG20.g 227 to 743 520 to 4       517/520
(99 %)
1 diff
(99.9 %id)
AI056454 B-cell, chronic lymphotic leukemia ISG20.g 296 to 748 459 to 7   tiling clone,   453/459
(98 %)
1 diff
(99.8 %id)
AW439360 serous papillary carcinoma, high grade, 2pooled tumors, uterus ISG20.g 302 to 748 444 to 1       444/444
(100 %)
6 diff
(98.7 %id)
BE646037 B-cell, chronic lymphotic leukemia ISG20.h 1 to 481 483 to 3 L12X tiling clone,   481/483
(99 %)
1 diff
(99.8 %id)
BU857280 adenocarcinoma, cell line, breast ISG20.i 1 to 542 1 to 543 R53K G83C H89N K92N H93L ... tiling clone,   543/931
(58 %)
45 diff
(95.2 %id)
AW966891   ISG20.j-u 1 to 761 1 to 762 exact tiling clone,   762/762
(100 %)
1 diff
(99.9 %id)
BQ052567 blood, natural killer cells, cell line ISG20.k 1 to 475 5 to 483   tiling clone,   483/1250
(38 %)
19 diff
(98.5 %id)
CR625782 B cells (Ramos cell line) Cot 25-normalized ISG20.k 157 to 2800 1 to 2644 exact tiling clone,   2644/2644
(100 %)
0 diff
(100 %id)
BC016341 Brain, primitive neuroectodermal ISG20.l 1 to 2699 1 to 2699 H34Y tiling clone, available from MGC, AAA   2699/2699
(100 %)
10 diff
(99.7 %id)
AW865851 stomach_normal ISG20.m-u 1 to 305 308 to 5   tiling clone,   304/308
(98 %)
0 diff
(100 %id)
AA203585 liver and spleen ISG20.m-u 147 to 731 1 to 580   tiling clone,   580/580
(100 %)
37 diff
(93.7 %id)
AI970632 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) ISG20.m-u 638 to 1039 403 to 2 exact tiling clone,   402/403
(99 %)
0 diff
(100 %id)
BF001245 colon, colon tumor, RER+ ISG20.m-u 642 to 1039 403 to 6 exact     398/413
(96 %)
0 diff
(100 %id)
AW009108 colon ISG20.m-u 681 to 1036 356 to 1 exact tiling clone,   356/356
(100 %)
0 diff
(100 %id)
BE675647 B-cell, chronic lymphotic leukemia ISG20.m-u 823 to 1064 242 to 1 exact tiling clone,   242/242
(100 %)
0 diff
(100 %id)
DA583976 lung ISG20.n 1 to 540 2 to 542 A2P E87X tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
BX342795   ISG20.n 23 to 977 1 to 942 exact tiling clone,   942/987
(95 %)
21 diff
(97.9 %id)
TI_149311570   ISG20.o 1 to 851 927 to 84 exact tiling clone, AAA   844/903
(93 %)
14 diff
(98.5 %id)
BU689494 lung, Primary Lung Cystic Fibrosis EpithelialCells ISG20.o 123 to 851 746 to 19 exact tiling clone, AAA   728/728
(100 %)
4 diff
(99.5 %id)
AA749343 germinal center B cell ISG20.p-u 1 to 384 386 to 1 exact tiling clone,   386/386
(100 %)
2 diff
(99.5 %id)
AV737297 cord Blood ISG20.q 1 to 383 47 to 423 Q62L I63S S64Q Q65R R66I ... tiling clone,   377/424
(88 %)
10 diff
(97.7 %id)
CR982005 T-Lymphocytes ISG20.r-u 1 to 345 1 to 343 R2Q tiling clone,   343/351
(97 %)
4 diff
(98.9 %id)
AJ714720 bone marrow ISG20.s 1 to 190 1 to 190 exact tiling clone,   190/190
(100 %)
0 diff
(100 %id)
AI830362 colon, colon tumor, RER+ Gene ISG20, variant not shown         Suspected internal deletion, this clone was ignored    
BI838470 pooled pancreas and spleen Gene ISG20, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57163109   Gene ISG20, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m-u, .n, .o, .p-u, .q, .r-u, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C